May 7 (Reuters) - CELYAD SA CYAD.BR :
* Q1 TREASURY POSITION OF EUR 33.8 MILLION
* CONFIRMS ITS PREVIOUS GUIDANCE THAT TREASURY POSITION
SHOULD BE
SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL EXPENDITURE
REQUIREMENTS THROUGH H1 2021
* Q1 NET CASH BURN EUR 5.5 MILLION
* WE ANTICIPATE ANNOUNCING ADDITIONAL DATA FROM OUR CYAD-101
ALLOSHRINK PHASE 1 TRIAL AT AMERICAN SOCIETY OF CLINICAL
ONCOLOGY - CEO
* WE ANTICIPATE FILING IND APPLICATION FOR OUR LEAD
SHRNA-BASED
ALLOGENEIC CANDIDATE CYAD-211 OVER NEXT FEW MONTHS - CEO
* WE ANTICIPATE PROVIDING CLINICAL UPDATE ON OUR
RELAPSED/REFRACTORY AML AND MDS PROGRAM IN H2 2020 - CEO
Source text for Eikon: ID:nGNX11qX9X
Further company coverage: CYAD.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))